- Article
- Open access
- Published:
- Kyle K. L. Phua1,5,
- Yi Liu1,
- Wei Zhang1,
- Jas-Min Chin1,
- Hong-Wen Tang4,
- Norbert Pardi3 &
- …
- Smita K. Nair2
Scientific Reports , Article number: (2026) Cite this article
We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.
Subjects
Abstract
Non-structural protein (NS1) derived from influenza A virus is a potent immune evasion protein capable of enhancing translation of nucleoside-modified mRNA via host gene expression inhibition (HGEI) effect. In this study, we show that the HGEI effect on NS1 transfected cells reduces de novo synthesis and polyadenylation of host RNA. Co-delivering NS1 mRNA also enhances translation of non-inflammatory nucleoside-modified and HPLC-purified mRNA in NIH3T3 cells. Co-delivering NS1 mRNA also enhances translation of nucleoside-modified mRNA in DCs by 100% based on GFP expression, but completely inhibits cytokine induced maturation of primary human dendritic cells (DCs). Co-delivering NS1 mRNA also significantly enhances in vivo translation of naked mRNA via intramuscular route with transgene expression persisting for 12 days. As a proof of concept to mimic natural viral infection, when mRNAs encoding NS1 and interferon alpha were co-delivered, translation inhibition of the reporter gene was rescued both in vitro and in vivo. Using ovalbumin as a model antigen, we show that humoral response in C57BL/6 mice was enhanced when naked mRNAs encoding ovalbumin, NS1 and IFN were delivered together via intramuscular route. These novel properties of NS1 have the potential to impact mRNA therapeutics in significant ways.
Data availability
Data generated or analyzed during this study are included in this published article. Other datasets used and/or analyzed during the current study can be made available from the corresponding author on reasonable request.
References
-
Phua, K. K., Leong, K. W. & Nair, S. K. Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format. J. Control Release. 166 (3), 227–233 (2013).
-
Perche, F. et al. Selective gene delivery in dendritic cells with mannosylated and histidylated lipopolyplexes. J. Drug Target. 19 (5), 315–325 (2011).
-
Pardi, N. et al. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. J. Control Release. 217, 345–351 (2015).
-
Kauffman, K. J., Webber, M. J. & Anderson, D. G. Materials for non-viral intracellular delivery of messenger RNA therapeutics. J. Control Release. 240, 227–234 (2016).
-
Golombek, S. et al. Intradermal delivery of synthetic mRNA using Hollow microneedles for efficient and rapid production of exogenous proteins in skin. Mol. Ther. Nucleic Acids. 11, 382–392 (2018).
-
Koh, K. J. et al. Formulation, characterization and evaluation of mRNA-loaded dissolvable polymeric microneedles (RNApatch). Sci. Rep. 8 (1), 11842 (2018).
-
Thess, A. et al. Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals. Mol. Ther. 23 (9), 1456–1464 (2015).
-
Baiersdorfer, M. et al. A facile method for the removal of DsRNA contaminant from in Vitro-Transcribed mRNA. Mol. Ther. Nucleic Acids. 15, 26–35 (2019).
-
Kariko, K. et al. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA. Nucleic Acids Res. 39 (21), e142 (2011).
-
Anderson, B. R. et al. Incorporation of Pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res. 38 (17), 5884–5892 (2010).
-
Devoldere, J. et al. Evading innate immunity in nonviral mRNA delivery: don’t shoot the messenger (Drug Discov Today, 2015).
-
Simon, R., Tassan, J. P. & Richter, J. D. Translational control by poly(A) elongation during xenopus development: differential repression and enhancement by a novel cytoplasmic polyadenylation element. Genes Dev. 6 (12B), 2580–2591 (1992).
-
Liu, Y. et al. Modulation of mRNA Translation and Cell Viability by Influenza A Virus Derived Nonstructural Protein 1 (Nucleic Acid Ther, 2018).
-
Liu, Y. et al. Messenger RNA translation enhancement by immune evasion proteins: a comparative study between EKB (vaccinia virus) and NS1 (influenza A virus). Sci. Rep. 9 (1), 11972 (2019).
-
Poleganov, M. A. et al. Efficient reprogramming of human fibroblasts and Blood-Derived endothelial progenitor cells using nonmodified RNA for reprogramming and immune evasion. Hum. Gene Ther. 26 (11), 751–766 (2015).
-
Phua, K. K. L., Liu, Y. & Sim, S. H. Non-linear enhancement of mRNA delivery efficiencies by influenza A derived NS1 protein engendering host gene Inhibition property. Biomaterials 133, 29–36 (2017).
-
Semple, S. C. et al. Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic acid. J. Pharmacol. Exp. Ther. 312 (3), 1020–1026 (2005).
-
Das, K. et al. Structural basis for suppression of a host antiviral response by influenza A virus. Proc. Natl. Acad. Sci. U S A. 105 (35), 13093–13098 (2008).
-
Khaperskyy, D. A. & McCormick, C. Timing is everything: coordinated control of host shutoff by influenza A virus NS1 and PA-X proteins. J. Virol. 89 (13), 6528–6531 (2015).
-
Nair, S., Archer, G. E. & Tedder, T. F. Isolation and generation of human dendritic cells. Curr. Protoc. Immunol. Chapter 7: p. Unit7 32. (2012)
-
Huang, R. L. et al. Opposing TNF-alpha/IL-1beta- and BMP-2-activated MAPK signaling pathways converge on Runx2 to regulate BMP-2-induced osteoblastic differentiation. Cell. Death Dis. 5, e1187 (2014).
-
Chen, Z. Y. et al. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol. Ther. 8 (3), 495–500 (2003).
-
Kuo, R. L. et al. Interactome analysis of NS1 protein encoded by influenza A H7N9 virus reveals an inhibitory role of NS1 in host mRNA maturation. J. Proteome Res. 17 (4), 1474–1484 (2018).
-
Salmena, L. et al. A CeRNA hypothesis: the Rosetta stone of a hidden RNA language? Cell 146 (3), 353–358 (2011).
-
Wang, X. et al. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J. Virol. 74 (24), 11566–11573 (2000).
-
Jia, D. et al. Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling. PLoS One. 5 (11), e13927 (2010).
-
Verbeke, R. et al. Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: restoring the immunogenicity of Immunosilent mRNA. J. Controlled Release. 266, 287–300 (2017).
-
Weissman, D. et al. HPLC purification of in vitro transcribed long RNA. Methods Mol. Biol. 969, 43–54 (2013).
Funding
This work was funded by the Young Individual Research Grant from the National Medical Research Council of Singapore (NMRC/OFYIRG/0028/2016).
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics
Primary human cells used in these experiments were isolated from blood obtained from healthy human volunteers following informed written consent using a protocol approved by the Duke University Institutional Review Board and carried out in accordance with relevant guidelines and regulations. Prior to conducting the research described in this paper, the experimenters were trained in “Responsible Care and Use of Laboratory Animals” as required by the National Advisory Committee for Laboratory Animal Research (NACLAR) in Singapore. The facilities at National University of Singapore (NUS) are fully accredited by the American Association for Accreditation of Laboratory Animal Care (AAALAC) and all animal experiments were conducted in accordance with relevant guidelines and regulations and based on protocol approved by NUS Institutional Animal Care and Use Committee (IACUC). All methods were conducted in accordance with ARRIVE guidelines.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Phua, K.K.L., Liu, Y., Zhang, W. et al. Influenza A virus derived NS1 enhances translation of HPLC purified mRNA and interferon adjuvanted mRNA vaccination. Sci Rep (2026). https://doi.org/10.1038/s41598-026-35611-5
-
Received:
-
Accepted:
-
Published:
-
DOI: https://doi.org/10.1038/s41598-026-35611-5
